Publications in collaboration with researchers from University College London (35)

2024

  1. Hematopoietic stem cell gene editing rescues B-cell development in X-linked agammaglobulinemia

    Journal of Allergy and Clinical Immunology, Vol. 154, Núm. 1, pp. 195-208.e8

  2. Minimal information for studies of extracellular vesicles (MISEV2023): From basic to advanced approaches

    Journal of Extracellular Vesicles, Vol. 13, Núm. 2

2023

  1. A second update on mapping the human genetic architecture of COVID-19

    Nature

2022

  1. DIPG Harbors Alterations Targetable by MEK Inhibitors, with Acquired Resistance Mechanisms Overcome by Combinatorial Inhibition

    Cancer Discovery, Vol. 12, Núm. 3, pp. 712-729

  2. Erratum: Author Correction: A multi-country test of brief reappraisal interventions on emotions during the COVID-19 pandemic (Nature human behaviour (2021) 5 8 (1089-1110))

    Nature human behaviour

  3. Erratum: Publisher Correction: Situational factors shape moral judgements in the trolley dilemma in Eastern, Southern and Western countries in a culturally diverse sample (Nature human behaviour (2022) 6 6 (880-895))

    Nature human behaviour

  4. INSIGHTS INTO THE HABITS OF THE ELUSIVE NOCTURNAL CURASSOW (NOTHOCRAX URUMUTUM)

    Ornitologia Neotropical, Vol. 33, Núm. 1, pp. 74-78

  5. Situational factors shape moral judgements in the trolley dilemma in Eastern, Southern and Western countries in a culturally diverse sample

    Nature Human Behaviour, Vol. 6, Núm. 6, pp. 880-895

2021

  1. A multi-country test of brief reappraisal interventions on emotions during the COVID-19 pandemic

    Nature Human Behaviour, Vol. 5, Núm. 8, pp. 1089-1110

  2. Droplet digital PCR-based detection of circulating tumor DNA from pediatric high grade and diffuse midline glioma patients

    Neuro-Oncology Advances, Vol. 3, Núm. 1

2020

  1. Population pharmacokinetics and pharmacogenetics of ritonavir-boosted darunavir in the presence of raltegravir or tenofovir disoproxil fumarate/emtricitabine in HIV-infected adults and the relationship with virological response: A sub-study of the NEAT001/ANRS143 randomized trial

    Journal of Antimicrobial Chemotherapy, Vol. 75, Núm. 3, pp. 628-639

2019

  1. HIV-1 molecular transmission clusters in nine European countries and Canada: Association with demographic and clinical factors

    BMC Medicine, Vol. 17, Núm. 1

2018

  1. Increased indoleamine-2,3-dioxygenase activity is associated with poor clinical outcome in adults hospitalized with influenza in the INSIGHT FLU003Plus study

    Open Forum Infectious Diseases, Vol. 5, Núm. 1

2017

  1. CD4 cell count response to first-line combination ART in HIV-2+ patients compared with HIV-1+ patients: A multinational, multicohort European study

    Journal of Antimicrobial Chemotherapy, Vol. 72, Núm. 10, pp. 2869-2878

  2. Report from the II Melanoma Translational Meeting of the Spanish Melanoma Group (GEM)

    Annals of Translational Medicine, Vol. 5, Núm. 19

2016

  1. Antiretroviral resistance at virological failure in the NEAT 001/ANRS 143 trial: Raltegravir plus darunavir/ritonavir or tenofovir/emtricitabine plus darunavir/ritonavir as first-line ART

    Journal of Antimicrobial Chemotherapy, Vol. 71, Núm. 4, pp. 1056-1062

  2. Host and disease factors are associated with cognitive function in European HIV-infected adults prior to initiation of antiretroviral therapy

    HIV Medicine, Vol. 17, Núm. 6, pp. 471-478

  3. Infection-related and -unrelated malignancies, HIV and the aging population

    HIV Medicine, Vol. 17, Núm. 8, pp. 590-600

2015

  1. Changing utilization of Stavudine (d4T) in HIV-positive people in 2006-2013 in the EuroSIDA study

    HIV Medicine, Vol. 16, Núm. 9, pp. 533-543

  2. Development and Validation of a Risk Score for Chronic Kidney Disease in HIV Infection Using Prospective Cohort Data from the D:A:D Study

    PLoS Medicine, Vol. 12, Núm. 3